Although an increase in heart-rate per se is not a major problem for most people, it is salient in the case of GLP1R, GIPR or GR agonists since the target patient population of these agonist are obese patients, who likely already suffer from cardiovascular complications
Some patients benefit from transitioning to non-pharmacological weight management strategies during the planning phase, while others may need brief insulin therapy or older-generation diabetes medications if blood sugar control remains a concern
Ongoing collaboration with pharmaceutical companies is helping to make this in-demand drug class more accessible
It contains semaglutide combined with an absorption enhancer (SNAC) that facilitates uptake across the gastric mucosa when taken under specific fasting conditions
Alterations on the delivery of nutrients to the small intestine resulting from the fundoplication, which decreases the accommodating capacity of the stomach, may explain the rapid rise in glucose and enhanced GLP-1 release
One study found that over 75% of adults with Type 2 diabetes would prefer a daily pill over a weekly injectable treatment
